berberine has been researched along with Diabetic Cardiomyopathies in 5 studies
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Objective To explore the effect of berberine on cardiac fibrosis of diabetic rats by observing the expressions of serum transforming growth factor-β1 (TGF-β1), connective tissue growth factor (CTGF) , collagen type 1 (Col1) and collagen type 3 (Col3) in myocardial tissues of diabetic rats after berberine treatment." | 7.83 | [Berberine inhibits cardiac fibrosis of diabetic rats]. ( He, J; Liu, G; Lu, K; Shen, Y; Song, W, 2016) |
| "Objective To explore the effect of berberine on cardiac fibrosis of diabetic rats by observing the expressions of serum transforming growth factor-β1 (TGF-β1), connective tissue growth factor (CTGF) , collagen type 1 (Col1) and collagen type 3 (Col3) in myocardial tissues of diabetic rats after berberine treatment." | 3.83 | [Berberine inhibits cardiac fibrosis of diabetic rats]. ( He, J; Liu, G; Lu, K; Shen, Y; Song, W, 2016) |
| "Berberine (BBR) is a natural compound extracted from a Chinese herb, with a clinically reported anti‑DCM effect; however, its molecular mechanisms have not yet been fully elucidated." | 1.91 | Berberine blocks inflammasome activation and alleviates diabetic cardiomyopathy via the miR‑18a‑3p/Gsdmd pathway. ( Cai, SQ; Chen, DF; Cheng, CF; Fang, HC; Huang, XJ; Li, ZF; Liu, HL; Ren, ZX; Xiong, Y; Yang, L; Ye, SY; Zhao, LJ, 2023) |
| "Berberine treatment of palmitate-incubated H9c2 cells reduced hypertrophy, increased α-MHC expression and decreased β-MHC expression." | 1.42 | Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells. ( Chang, W; Chen, L; Hatch, GM; Meng, Z; Yao, F; Yu, Y; Zhang, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, L | 1 |
| Cheng, CF | 1 |
| Li, ZF | 1 |
| Huang, XJ | 1 |
| Cai, SQ | 1 |
| Ye, SY | 1 |
| Zhao, LJ | 1 |
| Xiong, Y | 1 |
| Chen, DF | 1 |
| Liu, HL | 1 |
| Ren, ZX | 1 |
| Fang, HC | 1 |
| Li, G | 1 |
| Xing, W | 1 |
| Zhang, M | 3 |
| Geng, F | 1 |
| Yang, H | 1 |
| Zhang, H | 1 |
| Zhang, X | 1 |
| Li, J | 1 |
| Dong, L | 1 |
| Gao, F | 1 |
| Chang, W | 2 |
| Meng, Z | 1 |
| Yu, Y | 2 |
| Yao, F | 2 |
| Hatch, GM | 2 |
| Chen, L | 2 |
| Li, K | 1 |
| Guan, F | 1 |
| Lu, K | 1 |
| Shen, Y | 1 |
| He, J | 1 |
| Liu, G | 1 |
| Song, W | 1 |
5 other studies available for berberine and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Berberine blocks inflammasome activation and alleviates diabetic cardiomyopathy via the miR‑18a‑3p/Gsdmd pathway.
Topics: Animals; Berberine; Diabetes Mellitus; Diabetic Cardiomyopathies; Inflammasomes; MicroRNAs; Pyroptos | 2023 |
Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
Topics: Actins; Animals; Berberine; Blood Glucose; Cell Differentiation; Cell Proliferation; Cells, Cultured | 2018 |
Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Cardiomegaly; Cell Line; Diabetes Mellitus, Type | 2015 |
Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Topics: AMP-Activated Protein Kinases; Animals; Arrhythmias, Cardiac; Berberine; Biomarkers; Blood Glucose; | 2016 |
[Berberine inhibits cardiac fibrosis of diabetic rats].
Topics: Animals; Berberine; Collagen Type III; Connective Tissue Growth Factor; Diabetes Mellitus, Experimen | 2016 |